Evaluation of Vancomycin Administered in Different Dosage in Rats MRSA Pneumonia Model

张义永,马筱玲,荚恒敏,杜飞,吕小艳,何皖伟

DOI: https://doi.org/10.3969/j.issn.1009-6469.2012.12.007

2012-01-01

Abstract:Objective To evaluate different dosing regimen of vancomycin in treating MRSA pneumonia of rat model.Methods The rats which were infected with standard strains of ATCC43300 for pneumonia were divided into four groups,according to the administration of different dosages:groupⅠ(40 mg·kg-1,qd),group Ⅱ(20 mg·kg-1,qd),group Ⅲ(10 mg·kg-1,qd),group Ⅳ(20 mg·kg-1,bid).Plasma samples were collected at 10,20,30,60,90,120 min after drug administration,concentrations in serum were determined by using microbiological assays,the effects of different drug dosage were evaluated.Results The statistics showed that on the whole of rats in each group the survival rate gradually increased with the increased dose,but the difference was not statistically significant(P0.05).The colony counts in lung homogenates of all treatment groups were lower than those of the model group(P0.05);the bacterial counts of the lungs in groupⅠ and groupⅡ,group Ⅳ had no significant difference(P0.05);however they,had significant difference among groupⅠ,groupⅡand group Ⅲ(P0.05).Conclusions The efficacy doesn't rise with the increased drug concentration after reaching a certain peak concentration of vancomycin.There was no significant difference in efficacy in the twice daily dosing with the single dose.